Funding for this research was provided by:
National Institutes of Health (5R01HD092326, 5R01HD092326)
Received: 15 June 2021
Accepted: 18 April 2022
First Online: 26 April 2022
: This study was reviewed and approved by the Research Ethics Board at the University of Toronto (protocol number 35018); all methods were performed in accordance with relevant guidelines and regulations from the Declarations of Helsinki and the Tri-Council Policy Statement on Research Ethics. To assess capacity to consent, individuals with IDD were asked additional screening questions. Before each interview, participants provided written informed consent.
: Not applicable.